National Bank of Canada
PACB icon

National Bank of Canada’s Pacific Biosciences PACB Stock Holding History

National Bank of Canada’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-243
Closed -$28.7K – 3171
2025
Q1 		$28.7K Buy
+243
New +$373 ﹤0.01% 2004

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
BLAM
Bourne Lent Asset Management Pawling, New York $289M AUM 30.86% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return

National Bank of Canada's PACB Position: Q2 2026 in Review

National Bank of Canada increased its Pacific Biosciences (PACB) stake by 101% in Q2 2026, buying an estimated $289 and bringing the position to 397 shares worth $663. The position accounts for ﹤0.01% of the portfolio, ranked #2813.

National Bank of Canada first reported a position in PACB in Q4 2021 and has held it in 15 quarters since. The position peaked at $1.34M in Q2 2025. 107 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • National Bank of Canada held 397 shares of Pacific Biosciences worth $663 as of Q2 2026.
  • National Bank of Canada bought 199 Pacific Biosciences shares in Q2 2026, an estimated $289.
  • Pacific Biosciences made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #2813 holding.
  • National Bank of Canada first reported a position in Pacific Biosciences in Q4 2021 and has held it in 15 quarters since.
  • National Bank of Canada's Pacific Biosciences position peaked at $1.34M in Q2 2025.
  • 107 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.